SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001654954-20-000575
Filing Date
2020-01-17
Accepted
2020-01-17 17:21:17
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B azrxs1424.htm 424B3 674340
2 IMAGE azrx.jpg GRAPHIC 4554
  Complete submission text file 0001654954-20-000575.txt   681821
Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226
Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855
AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-235768 | Film No.: 20534410
SIC: 2834 Pharmaceutical Preparations